Strong product portfolio in niche
categories
Emami operates in niche categories like cooling oils, pain balms, antiseptic creams and men’s fairness creams with dominant market shares. Emami enjoys strong pricing power in most segments, thanks to its dominant market shares and minimal competition from large companies. Emami continues to record healthy mid-double digit revenue growth in the domestic business, witnessing a ~20% CAGR over the past three years. The international business revenue contribution is expected to increase to 18-20% from current ~10% over the next five years led by strong growth in Bangladesh and GCC. We expect Emami to witness 16% revenue CAGR over FY13-15.
New product pipeline to secure long-term growth
Emami has an established track record of launching new brands and categories (like Men’s whitening cream) and transforming brands to block-buster brands. Emami continues to churn out new products that are either in niche segments or occupy differentiated positions within large categories. Over the past 2-3 years, Emami focused on growth in existing brands. However, in CY14, 3-4 new launches and brand extensions are likely to secure long-term growth. Emami is looking at OTC/healthcare as a future growth driver and is planning to expand its portfolio.
Margins to expand, recommend Buy
No comments:
Post a Comment